- Over 1.8 million people in UK have it, but two in five people (43%) with psoriasis are afraid to go outside for fear of being judged
- Over one in 10 won’t go on holiday (14%), or to the gym (14%) and more than one in 20 won’t go out to meet friends (7%), due to the physical and emotional impact of the debilitating condition
- Furthermore, 50% of people admitted they feel embarrassed to talk about their lifelong battle with psoriasis and a quarter (26%) feel stuck in a helpless treatment loop with limited options
THE autoimmune skin condition that affects nearly one in 50 people in the UK has knocked the nation’s confidence, according to new research.
In a poll by Philips Healthcare*, a shocking two in five people (43%) who live with psoriasis revealed the condition has lowered their self-esteem, put up a social barrier and stopped them from going outside.
The chronic disease – which appears as raised, red patches on the skin – is having such an emotional impact on Brits that more than one in 10 sufferers refuse to go on holiday (14%), or to the gym (14%) and more than one in 20 won’t go out to meet friends (7%).
In fact, 50% of people surveyed admitted they feel embarrassed to even talk about their psoriasis, while the majority (75%) simply turn to creams in hope of a quick fix.
Despite 60% of Brits currently suffering from or having suffered with a skin disease at some point during their lifetime, when visiting their GP, some of those with psoriasis revealed they feel stuck in a treatment loop (26%), not a priority (23%), frustrated (15%), ignored (16%) and believe their GP is clueless (14%).
Expert dermatologist, Professor Cherio said: ‘The poll highlights not only the social stigma of the condition, but also the limitations individuals feel when faced with treatment options. It is concerning that 1 in 10 have never tried anything at all and I can only assume this is due to a lack of awareness around psoriasis.
Studies continue to show that treating the disease is your best bet to improve your quality of life and reduce the risk of developing comorbidities.’
Prof. Dr. Matthias Born, Director Clinical & Scientific Affairs and Principal Scientist at Philips, says: ‘Psoriasis complicates millions of daily lives and disrupts countless relationships. For this reason, Philips Light Therapy team set out to create a world-first treatment for psoriasis sufferers to give them back control of the condition. Philips BlueControl enables users to manage symptoms at home and on the go.’